Clinical Trial: A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07619339) titled 'A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer' on May 27.

Brief Summary: The researchers are doing this study to find out whether the combination of tepotinib and ivonescimab is a safe and effective treatment for people with non-small cell lung cancer (NSCLC) that is positive for METex14 skipping. The researchers will test up to two different doses of tepotinib in combination with ivonescimab to find the best dose of tepotinib that causes few or mild side effects in participants.

Study Start Date: May 27

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer

Intervention: DRUG: Tepotin...